1. Home
  2. NTRA vs NTRS Comparison

NTRA vs NTRS Comparison

Compare NTRA & NTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$197.35

Market Cap

32.9B

Sector

Health Care

ML Signal

HOLD

NTRS

Northern Trust Corporation

HOLD

Current Price

$138.67

Market Cap

26.5B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
NTRS
Founded
2003
1889
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
32.9B
26.5B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
NTRA
NTRS
Price
$197.35
$138.67
Analyst Decision
Strong Buy
Hold
Analyst Count
14
14
Target Price
$259.07
$144.69
AVG Volume (30 Days)
1.0M
1.0M
Earning Date
05-19-2026
01-01-0001
Dividend Yield
N/A
2.23%
EPS Growth
0.65
N/A
EPS
N/A
N/A
Revenue
$210,939,000.00
N/A
Revenue This Year
$16.65
$8.13
Revenue Next Year
$19.22
$4.27
P/E Ratio
N/A
$16.88
Revenue Growth
N/A
N/A
52 Week Low
$125.38
$81.62
52 Week High
$256.36
$157.60

Technical Indicators

Market Signals
Indicator
NTRA
NTRS
Relative Strength Index (RSI) 36.47 40.75
Support Level $195.46 $122.28
Resistance Level $251.09 $141.25
Average True Range (ATR) 8.23 4.24
MACD -0.65 -0.63
Stochastic Oscillator 17.11 19.40

Price Performance

Historical Comparison
NTRA
NTRS

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About NTRS Northern Trust Corporation

Northern Trust is a leading provider of wealth management, asset servicing, asset management, and banking to corporations, institutions, affluent families, and individuals. Founded in Chicago in 1889, Northern Trust has offices in 20 states and Washington, D.C. as well as 23 locations in Canada, Europe, the Middle East, and Asia-Pacific. As of December 2024, Northern Trust had assets under custody or administration of $16.8 trillion and assets under management of $1.6 trillion.

Share on Social Networks: